InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Janux Therapeutics, Inc.

JANX Clue Score43
United States Fiscal year ends December CIK 0001817713 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Janeen Noel Doyle
2 Jun 2026
Chief Corp. & Bus. Dev. Ofcr
Sell
4,059
$14.03
$56.94K
Maria Dobek
11 May 2026
Vice President, Accounting
Sell
2,038
$14.17
$28.88K
Maria Dobek
2 Jan 2026
Vice President, Accounting
Sell
1,462
$13.73
$20.07K
Zachariah McIver
2 Jan 2026
Chief Medical Officer
Sell
2,714
$13.73
$37.26K
Charles M. Winter
2 Jan 2026
Chief Technical Officer
Sell
2,401
$13.73
$32.97K
David Alan Campbell
2 Jan 2026
President and CEO
Sell
8,072
$13.73
$110.83K
Thomas DiRaimondo
2 Jan 2026
Chief Scientific Officer
Sell
2,505
$13.73
$34.39K
Andrew Hollman Meyer
2 Jan 2026
Chief Business Officer
Sell
1,879
$13.73
$25.80K
Show all 12 transactions →

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 460,541
History held since 14 Jun 2021